Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Applied DNA Sciences, Inc. - Common Stock (NQ:APDN)

5.620 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Applied DNA Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
Via ACCESSWIRE
Looking Into Applied DNA Sciences's Recent Short Interest
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Via ACCESSWIRE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
Via ACCESSWIRE
Why Applied DNA Sciences (APDN) Stock Is Skyrocketing
Applied DNA Sciences has expanded its mpox testing services. Shares rose 37% after the announcement. 
Via Benzinga
Applied DNA Launches Mpox Clade I and Clade II Testing Service
Via ACCESSWIRE
Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan
Via ACCESSWIRE
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
Via ACCESSWIRE
Looking Into Applied DNA Sciences's Recent Short Interest
 
Via Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
A look at the top 20 most-searched tickers on Benzinga Pro for the month of August. 
Via Benzinga
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
Via ACCESSWIRE
Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?
Applied DNA Sciences stock surges as it seeks approval to expand its mpox virus test to cover additional clades. The company awaits a decision from NYSDOH following its validation package submission,... 
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I
Via ACCESSWIRE
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
 
Via Benzinga
Topics Stocks
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024
Applied DNA Sciences just reported results for the third quarter of 2024. 
Via InvestorPlace
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
Via ACCESSWIRE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Via ACCESSWIRE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit
Via ACCESSWIRE
Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability
Via ACCESSWIRE
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.